Israel leads the world in Covid-19 vaccinations per capita

London, Jan 2 (SocialNews.XYZ) As vaccination drive to end the pandemic slowly heats up, Israel is leading the world in Covid-19 vaccine doses per capita as the country has given vaccinations to more than one million people, more than 10 per cent of the country's nine million population.

Israel is leading the race with a rate of 11.55 vaccination doses per 100 people, according to statistics from the 'Our World in Data' website affiliated with Oxford University.

Israel began vaccinations on December 19 as the country secured supplies of the Pfizer-BioNTech vaccine after negotiations early on during the pandemic, according to a BBC report on Saturday.

More than one million people in the country have now received the first of the two doses of the vaccine.

Israel is followed by Bahrain at 3.49, the UK at 1.47 and the US at 0.84, the data showed.

The data revealed that 9.95 million people globally have received Covid-19 vaccine doses.

While China has administered Covid-19 vaccine doses to 4.5 million people, the US has given doses to 2.79 million people, less than one per cent of the country's population.

The UK has also given vaccine doses to more than one million people, according to 'Our World in Data' which is a collaboration between researchers at the Oxford University and the non-profit organisation 'Global Change Data Lab'.

Globally, more than 1.8 million people have lost their lives due to the pandemic.

Source: IANS

Facebook Comments

About Gopi

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Share

This website uses cookies.

%%footer%%